FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2975976475> ?p ?o ?g. }

• W2975976475 abstract "Triple negative breast cancer (TNBC) is a subtype of breast cancer which is defined by the lack of expression of standard molecular targets: estrogen and progesterone receptors and the lack of expression or amplification of human epidermal growth factor receptor 2. TNBC is characterised by aggressive progression, lack of standard therapies and poorer overall survival rates for patients. Existing targeted therapies are not applicable to this type of breast cancer; thus, conventional chemotherapy still remains the standard of care for the treatment of TNBC.The present work aims to develop functionalised biodegradable nanocarriers for the treatment of triple negative breast cancer using a novel triblock copolymer. Different strategies are used for the development of nanocarriers by taking advantage of endogenous specific stimulus or receptor expression in the triple negative breast cancer cells. In chapter 2, docetaxel (DTX)-loaded redox responsive crosslinked micelles are prepared using a novel biocompatible and biodegradable functionalised triblock copolymer mPEG-b-poly(D,L-lactide-co-α-N3-e-caprolactone) for the treatment of TNBC. The empty micelles do not show any cytotoxicity in vitro in three cell lines tested i.e. MDA-MB-231 (triple-negative breast cancer), MCF7 (breast cancer) and MCF10A (breast epithelial cell line), whereas DTX-loaded reducible crosslinked micelles exhibit higher cytotoxicity against TNBC cells. Crosslinked and non-crosslinked micelles show high cellular uptake in MDA-MB-231 TNBC cells which is found to be concentration-dependent. The DTX-loaded crosslinked micelles induce higher levels of apoptosis, as assessed by the annexin V/PI assay and increase the caspase 3/7 activity in MDA-MB-231 cells in comparison to the cells treated with DTX-loaded un-crosslinked micelles and free DTX. Biodistribution results in healthy mice show that crosslinked micelles have increased stability in vivo in comparison to their non-crosslinked counterpart. Moreover, both formulations are found to be well tolerated and do not promote any adverse effect in vivo. In chapter 3, a triple negative breast cancer 3D cell culture model is developed for assessing the efficacy of docetaxel (DTX)-loaded crosslinked micelles against TNBC three-dimensional (3D) multicellular tumour spheroids. In addition, the ability of the redox responsive DTX-loaded crosslinked micelles to overcome the DTX resistance of the TNBC tumour spheroids is also investigated. The results of the efficacy assays show that DTX-loaded crosslinked micelles have the best efficacy against TNBC spheroids compared to control (un-crosslinked micelles) and free DTX. Moreover, the results indicate that 3D tumour spheroids exhibited higher innate resistance, especially to free docetaxel.In chapter 4, EGFR-targeted polymeric micelles using a peptide (GE11) that binds specifically to EGF receptor are prepared for synergistic co-delivery of docetaxel (DTX) and doxorubicin (DOX) aiming to treat triple negative breast cancer tumours. Results show that GE11-linked micelles at different peptide densities do not promote any toxicity in normal epithelial and breast cancer cell lines. However, the 15% GE11-linked micelles have a higher uptake in 2D monolayer and 3D spheroids of TNBC when compared to the 25% GE11-linked micelles and untargeted micelles. In addition, an advanced 3D co-culture system model of triple negative breast cancer with a non-tumorigenic cell line is also developed for the future assessment of the safety and efficacy of the formulations.Taken together, the results demonstrate that the designed functionalised micelles can be a promising and effective carrier system for future clinical applications to TNBC." @default.
• W2975976475 created "2019-10-03" @default.
• W2975976475 creator A5068460951 @default.
• W2975976475 date "2019-07-22" @default.
• W2975976475 modified "2023-09-24" @default.
• W2975976475 title "Investigations of bioresponsive polymers in triple negative breast cancers" @default.
• W2975976475 hasPublicationYear "2019" @default.
• W2975976475 type Work @default.
• W2975976475 sameAs 2975976475 @default.
• W2975976475 citedByCount "0" @default.
• W2975976475 crossrefType "dissertation" @default.
• W2975976475 hasAuthorship W2975976475A5068460951 @default.
• W2975976475 hasConcept C109316439 @default.
• W2975976475 hasConcept C11268172 @default.
• W2975976475 hasConcept C121608353 @default.
• W2975976475 hasConcept C126322002 @default.
• W2975976475 hasConcept C178790620 @default.
• W2975976475 hasConcept C18150654 @default.
• W2975976475 hasConcept C184651966 @default.
• W2975976475 hasConcept C185592680 @default.
• W2975976475 hasConcept C190283241 @default.
• W2975976475 hasConcept C202751555 @default.
• W2975976475 hasConcept C2776694085 @default.
• W2975976475 hasConcept C2777292972 @default.
• W2975976475 hasConcept C2779820397 @default.
• W2975976475 hasConcept C2780110267 @default.
• W2975976475 hasConcept C2781190966 @default.
• W2975976475 hasConcept C502942594 @default.
• W2975976475 hasConcept C530470458 @default.
• W2975976475 hasConcept C55493867 @default.
• W2975976475 hasConcept C71924100 @default.
• W2975976475 hasConcept C84606932 @default.
• W2975976475 hasConcept C88634738 @default.
• W2975976475 hasConceptScore W2975976475C109316439 @default.
• W2975976475 hasConceptScore W2975976475C11268172 @default.
• W2975976475 hasConceptScore W2975976475C121608353 @default.
• W2975976475 hasConceptScore W2975976475C126322002 @default.
• W2975976475 hasConceptScore W2975976475C178790620 @default.
• W2975976475 hasConceptScore W2975976475C18150654 @default.
• W2975976475 hasConceptScore W2975976475C184651966 @default.
• W2975976475 hasConceptScore W2975976475C185592680 @default.
• W2975976475 hasConceptScore W2975976475C190283241 @default.
• W2975976475 hasConceptScore W2975976475C202751555 @default.
• W2975976475 hasConceptScore W2975976475C2776694085 @default.
• W2975976475 hasConceptScore W2975976475C2777292972 @default.
• W2975976475 hasConceptScore W2975976475C2779820397 @default.
• W2975976475 hasConceptScore W2975976475C2780110267 @default.
• W2975976475 hasConceptScore W2975976475C2781190966 @default.
• W2975976475 hasConceptScore W2975976475C502942594 @default.
• W2975976475 hasConceptScore W2975976475C530470458 @default.
• W2975976475 hasConceptScore W2975976475C55493867 @default.
• W2975976475 hasConceptScore W2975976475C71924100 @default.
• W2975976475 hasConceptScore W2975976475C84606932 @default.
• W2975976475 hasConceptScore W2975976475C88634738 @default.
• W2975976475 hasLocation W29759764751 @default.
• W2975976475 hasOpenAccess W2975976475 @default.
• W2975976475 hasPrimaryLocation W29759764751 @default.
• W2975976475 hasRelatedWork W1256084377 @default.
• W2975976475 hasRelatedWork W1968035235 @default.
• W2975976475 hasRelatedWork W2005204750 @default.
• W2975976475 hasRelatedWork W2020623713 @default.
• W2975976475 hasRelatedWork W2023962042 @default.
• W2975976475 hasRelatedWork W2073075774 @default.
• W2975976475 hasRelatedWork W2102911723 @default.
• W2975976475 hasRelatedWork W2397297897 @default.
• W2975976475 hasRelatedWork W2531049099 @default.
• W2975976475 hasRelatedWork W2547967226 @default.
• W2975976475 hasRelatedWork W2589269825 @default.
• W2975976475 hasRelatedWork W2735951095 @default.
• W2975976475 hasRelatedWork W2758858527 @default.
• W2975976475 hasRelatedWork W2898950713 @default.
• W2975976475 hasRelatedWork W2911737890 @default.
• W2975976475 hasRelatedWork W3023819306 @default.
• W2975976475 hasRelatedWork W3105497329 @default.
• W2975976475 hasRelatedWork W3174736060 @default.
• W2975976475 hasRelatedWork W3187447018 @default.
• W2975976475 hasRelatedWork W3191222098 @default.
• W2975976475 isParatext "false" @default.
• W2975976475 isRetracted "false" @default.
• W2975976475 magId "2975976475" @default.
• W2975976475 workType "dissertation" @default.